FDA ex­plains plans for new phar­ma­ceu­ti­cal qual­i­ty as­sess­ment sys­tem

As part of its work to im­prove and mod­ern­ize the qual­i­ty as­sess­ment of drug ap­pli­ca­tions, the FDA is de­vel­op­ing a new, more stan­dard­ized sys­tem, to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA